Catalent (CTLT) shares rise 1% as Novo Holdings explores contract extensions with concerned drugmakers post $16.5 billion sale.
https://seekingalpha.com/news/4360760-catalent-gains-amid-report-buyer-working-on-contact-extensions-with-drugmakers
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.